A carregar...
CHN1 is a Novel Prognostic Marker for Diffuse Large B-Cell Lymphoma
PURPOSE: Diffuse large B-cell lymphoma (DLBCL) is the most common B-cell malignancy. Thirty to forty percent of DLBCL patients still experience relapse or develop refractory disease even with standard immunochemotherapy, leading to a poor prognosis. Currently, although several gene-based classificat...
Na minha lista:
| Publicado no: | Pharmgenomics Pers Med |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8021264/ https://ncbi.nlm.nih.gov/pubmed/33833551 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S301718 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|